APOE and epilepsy: Compared with the APOE−/−+KA group, significant upregulation was identified in metabolic pathways such as glycine, serine, and threonine metabolism; glycerophospholipid metabolism; and the pentose phosphate pathway within the WT+KA epilepsy model.